not losing weight on compound semaglutide Why Am I Semaglutide: Medical Causes Explained 7 Reasons Why You're Not

The 13 states where Medicaid covers GLP-1 drugs for obesity are California, Kansas, Minnesota, Wisconsin, Michigan, Mississippi, Pennsylvania, Virginia, North Carolina, Massachusetts, New Hampshire, Delaware and Rhode Island

UK Focused Astra Labs is built for UK researchers who want clear product information, reliable communication and domestic dispatch

Sleep is when the body performs critical repair functions, including cell regeneration in hair follicles

L-glutamine is generally safe to take

Who GLP-1 weight loss is for - and who it isn't Patients we typically work with on GLP-1 weight management: Adults with BMI 30+ (obesity) who have not achieved sustained weight loss with lifestyle change alone Adults with BMI 27+ and weight-related comorbidities - type 2 diabetes, hypertension, dyslipidemia, sleep apnea, prediabetes, fatty liver disease Patients with insulin resistance or metabolic syndrome where the metabolic and weight pictures are intertwined Patients post-bariatric surgery with weight regain, where appropriate and coordinated with their surgical team GLP-1 medications are not appropriate for patients with personal or family history of medullary thyroid carcinoma, MEN2 syndrome, history of pancreatitis, severe gastroparesis, or active eating disorders

Alhomoud IS, Talasaz AH, Chandrasekaran P, Brown R, Mehta A, Dixon DL